Related Experiment Video
Updated: Feb 28, 2026
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck
Sophie C Siegmund1, Sebastian E Serfling2, Takahiro Higuchi3,4
1Department of Nuclear Medicine, University Hospital, LMU Munich, Germany, Munich.
Aim:
This review aims to explore the evolving field of theranostics in oncology, focusing on its potential application to head and neck squamous cell carcinoma (HNSCC). Specifically, it examines the integration of molecular imaging and radionuclide therapy in the context of theranostics.
Methods:
A comprehensive review of current literature was conducted to evaluate the state-of-the-art theranostic approaches in HNSCC. The review includes an analysis of established and emerging molecular targets relevant to HNSCC, as well as the potential for future theranostic developments.
Results:
The integration of theranostic principles into head and neck oncology is gaining momentum, with increasing interest in novel targets in the context of theranostics. Although [18F]FDG PET/CT still remains the dominant imaging modality in HNSCC, the application of novel radiotracers for imaging and radionuclide therapy holds considerable promise.
Conclusion:
Theranostics represents a promising future for head and neck oncology, offering the potential for personalized, biology-driven diagnostic and therapeutic strategies. While many emerging approaches are still under investigation, the combination of molecular imaging and targeted radionuclide therapy may significantly enhance the treatment of HNSCC, providing more precise and effective patient care in the future.1.
Insights
Theranostics combines molecular imaging and targeted radionuclide therapy for head and neck squamous cell carcinoma (HNSCC). This approach promises personalized, effective treatments for HNSCC patients.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiochemistry
Background:
- Theranostics integrates diagnostic imaging and targeted radionuclide therapy.
- Head and neck squamous cell carcinoma (HNSCC) management can benefit from advanced theranostic strategies.
Purpose of the Study:
- To review the current state and future potential of theranostics in HNSCC.
- To analyze molecular targets and radiotracers for HNSCC theranostics.
Main Methods:
- Comprehensive literature review of theranostic applications in HNSCC.
- Analysis of established and emerging molecular targets and imaging modalities.
Main Results:
- Theranostic principles are increasingly applied in head and neck oncology.
- Novel radiotracers show promise beyond [18F]FDG PET/CT for HNSCC imaging and therapy.
Conclusions:
- Theranostics offers a personalized, biology-driven approach for HNSCC.
- Combining molecular imaging and targeted radionuclide therapy may improve HNSCC treatment outcomes.
More Related Videos
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
